Try Alerts Free   |   Login
Technology › Optical Instruments And Lenses

IIVI Price Correlated With Financials For II-VI

Free historical financial statements for II-VI Inc. See how revenue, income, cash flow, and balance sheet financials have changed over 47 quarters since 2010. Compare with IIVI stock chart to see long term trends.

IIVI Stock Compared to Quarterly

IIVI Income Statement

Revenue, Net:827724000
Revenue Per Share:7.7752
Cost of Goods & Services Sold:506051000
Selling, General & Admin Expense:118009000
Research & Development Expense:96895000
Total Operating Expenses:764695000
Operating Income:106768000
Income Taxes:14027000
Net Income:49002000
Earnings Per Share, Basic:0.3
Shares Outstanding, Basic Avg:106456567

IIVI Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:72817000
Change in Accounts Receiveable:51784000
Net Cash from Operations:35922000
Net Cash from Operations Per Share:0.3374
Net Cash from Financing Activities:-19589000
Property, Plant & Equipment Purchases:94302000
Purchases of Businesses, Net of Cash:0
Net Cash from Investing Activities:-100052000
Net Change in Cash & Equivalents:-49401000

IIVI Balance Sheet

Cash and Cash Equivalents:2600315000
Accounts Receivable, Net:653095000
Total Current Assets:4233799000
Property, Plant & Equipment, Net:1320191000
Total Assets:7767196000
Accounts Payable:361533000
Current Portion of Long-Term Debt:1383959000
Total Short-Term Liabilities:2123881000
Long Term Debt, Non-Current Portion:928745000
Total Liabilities:3383020000

Major Holders (from 13F filings)

Investment Type
Value (x$1000)
increase or decrease
Blackrock Inc.
11,819,395 sh
490,303 sh
Vanguard Group Inc
10,345,350 sh
-4,750 sh
Dodge & Cox
6,722,041 sh
3,939,952 sh
Pictet Asset Management SA
3,216,697 sh
-400,191 sh
2,894,735 sh
-529,582 sh
American Century Companies Inc
2,616,262 sh
-144,032 sh
Neuberger Berman Group LLC
2,061,544 sh
-658,366 sh
JPMorgan Chase & Co
2,060,554 sh
-7,840 sh
Geode Capital Management, LLC
1,953,692 sh
15,439 sh
Morgan Stanley
1,935,991 sh
-64,223 sh
Northern Trust Corp
1,460,793 sh
-58,729 sh
Frontier Capital Management Co LLC
1,325,217 sh
-718,475 sh
Fort Pitt Capital Group, LLC
1,306,915 sh
29,243 sh
Invesco Ltd.
1,274,282 sh
84,479 sh
Channing Capital Management, LLC
1,254,778 sh
19,141 sh
Bank Of New York Mellon Corp
1,172,066 sh
5,707 sh
Rockefeller Capital Management L.P.
1,153,882 sh
-22,977 sh
Dimensional Fund Advisors LP
1,070,476 sh
-288,707 sh
Charles Schwab Investment Management Inc
917,602 sh
34,143 sh
Barrow Hanley Mewhinney & Strauss LLC
807,261 sh
-12,795 sh
Nature of Business and Summary of Significant Accounting Policies Nature of Business. II-VI Incorporated and its subsidiaries (the “Company,” “we,” “us,” or “our”), a global leader in engineered materials and optoelectronic components and devices, is a vertically-integrated manufacturing company that develops, manufactures and markets engineered materials and optoelectronic components and devices for precision use in industrial materials processing, optical communications, aerospace and defense, consumer electronics, semiconductor capital equipment, life sciences and automotive applications. The Company markets its products through its direct sales force and through distributors and agents.

The Company uses certain uncommon materials and compounds to manufacture its products. Some of these materials are available from only one proven outside source. The continued high quality of these materials is critical to the stability of the Company’s manufacturing yields. The Company has not experienced significant production delays due to a shortage of materials. However, the Company does occasionally experience problems associated with vendor-supplied materials not meeting specifications for quality or purity. A significant failure of the Company’s suppliers to deliver sufficient quantities of necessary high-quality materials on a timely basis could have a material adverse effect on the Company’s results of operations.

In March 2020, the World Health Organization declared the outbreak of COVID-19 as a pandemic, which continues to spread throughout the United States and world. The Company is closely monitoring the impact of the COVID-19 pandemic on all aspects of our business including the impact to our suppliers and customers as well as the impact to the countries and markets in which II-VI operates. At the onset of the COVID-19 outbreak, the Company began focusing intensely on mitigating the adverse impacts of COVID-19 on foreign and domestic operations starting by protecting its employees, suppliers and customers.

Principles of Consolidation. The Consolidated Financial Statements include the accounts of the Company. All intercompany transactions and balances have been eliminated.

Estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Foreign Currency Translation. For all foreign subsidiaries whose functional currency is not the U.S. dollar, the functional currency is the local currency. Assets and liabilities of those operations are translated into U.S. dollars using period-end exchange rates while income and expenses are translated using the average exchange rates for the reporting period. Translation adjustments are recorded as accumulated other comprehensive income (loss) within shareholders’ equity in the accompanying Consolidated Balance Sheets.

Cash and Cash Equivalents. The Company considers highly liquid investment instruments with an original maturity of three months or less to be cash equivalents. We place our cash and cash equivalents with high credit quality financial institutions and to date have not experienced credit losses in these instruments.

Accounts Receivable. The Company makes estimates evaluating its allowance for doubtful accounts. The Company continuously monitors collections and payments from its customers and maintains a provision for estimated credit losses based upon its historical experience, current market conditions and any specific customer collection issues that it has identified.

Inventories. Inventories are valued at the lower of cost or net realizable value, with cost det

Data imported from II-VI Inc SEC filings. Check original filings before making any investment decision.